Abstract
Background Scorpion envenomation is a public health problem that results in a life-threatening medical emergency in tropical and subtropical regions. Paediatric victims are more at risk to severe envenomation compared to adults.
Objectives This study aimed to determine clinical features and outcome of patients hospitalized due to scorpion stings at the Tesseney Community Hospital.
Methods A prospective, descriptive cross-sectional study conducted from 1st June 2019 to 31st May 2020 on patients hospitalized due to scorpion stings at the Tesseney Community Hospital.
Results 165 scorpion sting patients were admitted during the study period. Majority were older than 15 years old (61.8%) with an approximately equal male-to-female sex ratio (0.94:1). Scorpion sting cases largely belonged to urban (57%) compared to rural areas. The black scorpion (38.8%) was the predominately identified scorpion, but in a proportion of cases the scorpion colour was undetermined (31.5%). The foot was predominate sting site (64.8%) followed by hand (31.5%). A single sting (91.5%) was more frequently presented compared to multiple stings (8.5%). Majority (94.8%) of scorpion sting cases occurred during the summer period with highest scorpion stings counts belonging to September and October. The main clinical manifestations upon presentation were localized pain (70.3%) and sweating (56.4%) with more severe symptoms exhibited amongst age groups less than 15 years old. The fatality rate (4.8%) was largely associated age groups less than 15 years old with (p = 0.006, OR: 2.845; 95% CI: 0.656-12.343).
Conclusion Our study found children experienced more severe envenoming symptoms with related mortality compared to adults. This study may be a tool to identify at-risk population groups and build measures to prevent scorpion stings within the western lowlands of Eritrea.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from zonal branch of Ministry of Health Research and Ethical Approval Committee and a written informed consent obtained from the patient to participate in this report and publish.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data will be available from the hospital registry department.
